Your browser doesn't support JavaScript. Please upgrade to a modern browser or enable JavaScript in your existing browser.
Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Appendix Figure 1. Screening for Postmenopausal Osteoporosis. Analytic Framework

Analytic Framework. For details, go to [D] Text Description below.

[D] Text Description

Key Questions:

Arrow 1: Does screening using risk factor assessment and/ or bone density testing reduce fractures?
Arrow 2: Does risk factor assessment accurately identify women who may benefit from bone density testing?
Arrow 3: Do bone density measurements accurately identify women who may benefit from treatment?
Arrow 4: What are the harms of screening?
Arrow 5: Does treatment reduce the risk of fractures in women identified by screening?
Arrow 6: What are the harms of treatment?

The analytic framework is a schematic outline used to define the population, preventive service, diagnostic or therapeutic interventions, and intermediate and health outcomes considered in the review. The arrows represent key questions that the evidence must answer, and demonstrate the chain of logic that evidence must support, to link the preventive service to improved health outcomes.

Return to Document

 

AHRQ Advancing Excellence in Health Care